Finally, using western blotting, we showed that the effects of HNRNPC inhibition on CDK4, cyclin E1, and c-myc levels in HCC cells were reversed by ML-098 to some extent (Figures 6C, D). The gene discussed is MYC; the disease is hepatocellular carcinoma.